|
45
|
Grafted polyvinylpyrrolidone (PVP) |
Polyvinyl chloride (PVC) medical catheters |
E. coli
|
Fouling resistance of 99.98% against E. coli
|
| Good compatibility |
| High surface hydrophilicity |
|
58
|
Poly(ethylene glycol) (PEG), antithrombotic peptide ACH11 |
Au substrates |
Platelet |
Excellent hydrophilic property |
| Strong antiprotein and antiplatelet attachment ability |
| Excellent hemocompatibility |
| Inhibiting granulation formation and fibrous capsule |
|
59
|
Ploy(glycidyl methacrylate-co-sulfobetaine methacrylate) (poly(GMA-co-SBMA)) |
Silicon, glass, titanium, stainless steel, and polymers |
Human blood cells, fibroblast cells, E. coli
|
Reduced by 89.3%, 73.7%, 76.5%, 77.9%, and 49.6%, for platelet adhesion and by 96.1%, 96.2%, 83.7%, 88.1%, and 87% for erythrocyte adhesion with the surfaces respectively |
| A high reduction in human fibroblast (HT1080) adhesion of 96.3%, 96.5%, 91.3%, 86.3%, and 57.8% respectively |
| The high reduction in bacterial attachment of 88.5%, 79.7%, 86.9%, 90.8%, and 51.4% respectively |
|
60
|
N,N-Dimethylacrylamide (DMAAm) |
Liposomes |
N/A |
Increased in surface softness |
|
63
|
3-Aminopropylmethacrylamide (APMA), poly(ethylene glycol) methacrylate (PEGMA) |
Poly(d,l-lactic acid) (PLA) |
Human immortalized mesenchymal stem cell (hiMSCs), cardiomyocytes derived from human-induced pluripotent stem cells (hiPSC-CMs) |
Non-cytotoxic to hiMSCs |
| The size and number of hiMSC |
| Aggregates formed are primarily influenced by the surface chemistry of the incorporated microparticles |
